Jill U. Adams is a freelance science journalist based in Albany, New York. She covers health, mental health and biomedical research for such publications as The Transmitter, The Washington Post, Scientific American, Undark and The Scientist. She has a Ph.D. in pharmacology from Emory University in Atlanta, Georgia.
Jill Adams
Contributing writer
From this contributor
Pangenomic approaches to the genetics of autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 February.
Pangenomic approaches to the genetics of autism, and more
By
Jill Adams
3 February 2026 | 2 min read
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
FDA website no longer warns against bogus autism therapies, and more
By
Jill Adams
27 January 2026 | 2 min read
Sensory profiles in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 January.
Alzheimer’s disease and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 January.
Profiles of neurodevelopmental conditions; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 January.
Profiles of neurodevelopmental conditions; and more
By
Jill Adams
6 January 2026 | 1 min read
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 5 min read